Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy.

The aim of the study is to evaluate the effect of fluconazole antifungal prophylaxis on the severity of mucositis in head and neck cancer patients receiving radiotherapy.
Sixty-three patients, with malignant head and neck tumor, eligible to receive radiotherapy, entered the study. Thirty-four patients (group A) received 100 mg/day of fluconazole prophylaxis during radiotherapy and were compared with 29 patients, who received radiotherapy alone (group B). The two groups were similar in terms of patients and radiotherapy characteristics. Smear to test for Candida carriage was taken before and after radiotherapy. Oral candidiasis was diagnosed using the criteria described before. Oral mucositis was recorded according to EORTC/RTOG criteria.
A significant reduction of severe mucositis at the end of radiotherapy (14.7 vs 44.8%, p=0.018) and of interruptions (0 vs 17.2%, p=0.017) was observed in group A. Candidiasis was prevented (0 vs 34.5%, p=0.001), with a significant reduction of Candida carriage of 40.7% (p=0.001).
Fluconazole prophylaxis showed a significant beneficial impact on the severity of mucositis and on radiotherapy interruptions in this group of patients. The current study provides data on the build of a randomized controlled trial on the effect of fluconazole prophylaxis on treatment schedule and quality of life of the patients during head and neck radiotherapy.
AuthorsOurania Nicolatou-Galitis, Aristea Velegraki, Anastasia Sotiropoulou-Lontou, Konstantinos Dardoufas, Vassilis Kouloulias, Konstantinos Kyprianou, Georgia Kolitsi, Christos Skarleas, George Pissakas, Vassilis S Papanicolaou, John Kouvaris
JournalSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (Support Care Cancer) Vol. 14 Issue 1 Pg. 44-51 (Jan 2006) ISSN: 0941-4355 [Print] Germany
PMID15947956 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antifungal Agents
  • Fluconazole
  • Adult
  • Aged
  • Aged, 80 and over
  • Antifungal Agents (therapeutic use)
  • Candidiasis, Oral (etiology, prevention & control)
  • Drug Resistance, Fungal
  • Female
  • Fluconazole (therapeutic use)
  • Head and Neck Neoplasms (radiotherapy)
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Radiation Injuries (etiology, pathology, prevention & control)
  • Radiotherapy (adverse effects)
  • Severity of Illness Index
  • Stomatitis (etiology, pathology, prevention & control)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: